Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Interstitial Cell Tumor

9,10-dimethyl-1,2-benzanthracene has been researched along with Interstitial Cell Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, BJ; Mandal, PK; McDaniel, LR; Prough, RA1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Interstitial Cell Tumor

ArticleYear
7,12-Dimethylbenz[a]anthracene inhibition of steroid production in MA-10 mouse Leydig tumor cells is not directly linked to induction of CYP1B1.
    Toxicology and applied pharmacology, 2001, Sep-15, Volume: 175, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Androgen Antagonists; Animals; Aryl Hydrocarbon Hydroxylases; Benz(a)Anthracenes; Chorionic Gonadotropin; Cyclic AMP; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Leydig Cell Tumor; Leydig Cells; Male; Mice; Polychlorinated Dibenzodioxins; Progesterone; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Tumor Cells, Cultured

2001